Price $0.98 |
Market Cap
89.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
7.64
|
P/S
8.49
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-18.1K
|
FCF
-0.2
|
|
Op. Margin
-
|
Net Margin
-309.50%
|
ROE
-122.10%
|
ROI
-282.80%
|
|
ROA
-63.60%
|
EPS Growth
47.30%
|
Current Ratio
1.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Emmaus Life Sciences Inc (EMMA) | $0.31 | - | - | 16.4M | Strong Buy |
| Taysha Gene Therapies Inc (TSHA) | $0.70 | - | - | 46M | Strong Buy |
| Medicine Man Technologies Inc (SHWZ) | $1.01 | - | - | 59.4M | Strong Buy |
| Aquestive Therapeutics Inc (AQST) | $2.24 | - | - | 63.1M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $7.45 | - | - | 9.93B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
